Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer
- PMID: 5030811
Item in Clipboard
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer
Cancer Chemother Rep.
1972 Feb.
No abstract available
Similar articles
-
Treatment of malignant melanoma with camptothecin (NSC-100880).Cancer Chemother Rep. 1972 Feb;56(1):103-5. Cancer Chemother Rep. 1972. PMID: 5030802 No abstract available.
-
Combination chemotherapy in gastrointestinal cancer.Cancer Res. 1970 May;30(5):1425-8. Cancer Res. 1970. PMID: 4246651 No abstract available.
-
Oral administration of fluorouracil. A preliminary trial.Arch Surg. 1968 Oct;97(4):654-6. doi: 10.1001/archsurg.1968.01340040150030. Arch Surg. 1968. PMID: 5678137 No abstract available.
-
[Gastrointestinal complication of cancer chemotherapy].Nihon Rinsho. 2007 Oct 28;65 Suppl 8:281-6. Nihon Rinsho. 2007. PMID: 18074549 Review. Japanese. No abstract available.
-
What primary care physicians should know about the toxicity of cancer chemotherapy.Cleve Clin J Med. 1997 Jun;64(6):331-3. doi: 10.3949/ccjm.64.6.331. Cleve Clin J Med. 1997. PMID: 9188216 Review. No abstract available.
Cited by
-
A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer.Invest New Drugs. 2004 Jan;22(1):69-73. doi: 10.1023/b:drug.0000006176.84915.71. Invest New Drugs. 2004. PMID: 14707496 Clinical Trial.
-
Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus.Antimicrob Agents Chemother. 2012 Feb;56(2):893-902. doi: 10.1128/AAC.05274-11. Epub 2011 Nov 21. Antimicrob Agents Chemother. 2012. PMID: 22106228 Free PMC article.
-
Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy.Mol Pharm. 2022 Dec 5;19(12):4665-4674. doi: 10.1021/acs.molpharmaceut.2c00701. Epub 2022 Nov 22. Mol Pharm. 2022. PMID: 36413426 Free PMC article.
-
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma.Invest New Drugs. 1998-1999;16(4):341-6. doi: 10.1023/a:1006248700232. Invest New Drugs. 1998. PMID: 10426669 Clinical Trial.
-
Potential Antiviral Action of Alkaloids.Molecules. 2022 Jan 28;27(3):903. doi: 10.3390/molecules27030903. Molecules. 2022. PMID: 35164173 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources